Incorporation of a Genetic Factor into an Epidemiologic Model for Prediction of Individual Risk of Lung Cancer: The Liverpool Lung Project

被引:44
|
作者
Raji, Olaide Y. [1 ]
Agbaje, Olorunsola F. [2 ]
Duffy, Stephen W. [3 ]
Cassidy, Adrian [1 ]
Field, John K. [1 ]
机构
[1] Univ Liverpool, Canc Res Ctr, Roy Castle Lung Canc Res Programme, Sch Canc Studies, Liverpool L3 9TA, Merseyside, England
[2] Kings Coll London, Div Canc Studies, Canc Epidemiol Unit, Sch Med,Guys Hosp, London WC2R 2LS, England
[3] Queen Mary Univ London, Canc Res UK Ctr EMS, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London, England
关键词
LOGISTIC-REGRESSION-MODEL; BREAST-CANCER; SEZ6L GENE; FIT TESTS; IDENTIFICATION; BIOMARKERS; GOODNESS; AREA; AGE;
D O I
10.1158/1940-6207.CAPR-09-0141
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Liverpool Lung Project (LLP) has previously developed a risk model for prediction of 5-year absolute risk of lung cancer based on five epidemiologic risk factors. SEZ6L, a Met430IIe polymorphic variant found on 22q12.2 region, has been previously linked with an increased risk of lung cancer in a case-control population. In this article, we quantify the improvement in risk prediction with addition of SEZ6L to the LLP risk model. Data from 388 LLP subjects genotyped for SEZ6L single-nucleotide polymorphism (SNP) were combined with epidemiologic risk factors. Multivariable conditional logistic regression was used to predict 5-year absolute risk of lung cancer with and without this SNP. The improvement in the model associated with the SEZ6L SNP was assessed through pairwise comparison of the area under the receiver operating characteristic curve and the net reclassification improvements (NRI). The extended model showed better calibration compared with the baseline model. There was a statistically significant modest increase in the area under the receiver operating characteristic curve when SEZ6L was added into the baseline model. The NRI also revealed a statistically significant improvement of around 12% for the extended model; this improvement was better for subjects classified into the two intermediate-risk categories by the baseline model (NRI, 27%). Our results suggest that the addition of SEZ6L improved the performance of the LLP risk model, particularly for subjects whose initial absolute risks were unable to discriminate into "low-risk" or "high-risk" group. This work shows an approach to incorporate genetic biomarkers in risk models for predicting an individual's lung cancer risk. Cancer Prev Res; 3(5); 664-9. (C) 2010 AACR.
引用
收藏
页码:664 / 669
页数:6
相关论文
共 50 条
  • [41] Interstitial Lung Abnormalities as an Independent Risk Factor for Lung Cancer
    Whittaker, S.
    Padilla, M. L.
    Mhango, G.
    Powell, C. A.
    Henschke, C.
    Yankelevitz, D.
    Salvatore, M.
    de Torres, J. P.
    Wisnivesky, J. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [42] Genetic Variants of HUNT Lung Cancer Model Improve Lung Cancer Risk Assessment Over Clinical Models
    Nguyen, O. T. D.
    Fotopoulos, I.
    Nost, T. H.
    Markaki, M.
    Lagani, V.
    Tsamardinos, I.
    Roe, O. D.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S81 - S81
  • [43] Distribution of predictable risk for lung cancer: Use of a lung cancer prediction tool
    Barrera, R
    Bach, PB
    Gabovich, N
    Saeed, M
    White, DA
    CHEST, 2003, 124 (04) : 118S - 118S
  • [44] Development and Validation of a Risk Prediction Model for Second Primary Lung Cancer
    Choi, Eunji
    Sanyal, Nilotpal
    Ding, Victoria Y.
    Gardner, Rebecca M.
    Aredo, Jacqueline, V
    Lee, Justin
    Wu, Julie T.
    Hickey, Thomas P.
    Barrett, Brian
    Riley, Thomas L.
    Wilkens, Lynne R.
    Leung, Ann N.
    Le Marchand, Loic
    Tammemagi, Martin C.
    Hung, Rayjean J.
    Amos, Christopher, I
    Freedman, Neal D.
    Cheng, Iona
    Wakelee, Heather A.
    Han, Summer S.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (01): : 87 - 96
  • [45] LUNGpro: Design and validation of a lung cancer mendelian risk prediction model
    Doan, Betty
    Bailey-Wilson, Joan
    Parmigiani, Giovanni
    CANCER RESEARCH, 2008, 68 (09)
  • [46] External validation of a risk prediction model for lung cancer among smokers
    Sakoda, Lori C.
    Habel, Laurel A.
    Thai, Khanh K.
    Quesenberry, Charles P., Jr.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (05)
  • [47] A smoking-based carcinogenesis model for lung cancer risk prediction
    Foy, Millennia
    Spitz, Margaret R.
    Kimmel, Marek
    Gorlova, Olga Y.
    INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (08) : 1907 - 1913
  • [48] Accuracy of the Vancouver Lung Cancer Risk Prediction Model Compared With That of Radiologists
    MacMahon, Heber
    Li, Feng
    Jiang, Yulei
    Armato, Samuel G., III
    CHEST, 2019, 156 (01) : 112 - 119
  • [49] The Cytokinesis-Blocked Micronucleus Assay as a Strong Predictor of Lung Cancer: Extension of a Lung Cancer Risk Prediction Model
    El-Zein, Randa A.
    Lopez, Mirtha S.
    D'Amelio, Anthony M., Jr.
    Liu, Mei
    Munden, Reginald F.
    Christiani, David
    Su, Li
    Tejera-Alveraz, Paula
    Zhai, Rihong
    Spitz, Margaret R.
    Etzel, Carol J.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (11) : 2462 - 2470
  • [50] Genetic abnormality, tobacco smoke, lung disease, and lung cancer risk
    Sun Z
    De Andrade, M.
    Krowka, M. J.
    Aubry, M. C.
    Scanlon, P. D.
    Bamlet, W. R.
    Wampfler, J. A.
    Thibodeau, S. N.
    Katzmann, J. A.
    Allen, M. S.
    Midthun, D. E.
    Marks, R. S.
    Yang, P.
    GENETIC EPIDEMIOLOGY, 2007, 31 (05) : 499 - 499